Search

Your search keyword '"Terrada, C."' showing total 147 results
Start Over Author "Terrada, C."
147 results on '"Terrada, C."'

3. Essai randomisé, multicentrique évaluant l’efficacité et la tolérance de l’adalimumab, de l’anakinra et du tocilizumab dans les uvéites réfractaires non infectieuses (RUBI)

Author

Saadoun, D., Ghembaza, A., Sarah, T., Girszyn, N., Philip, B., S. P., Grégory, P., Marc, A., Mathilde, L., Thomas, R., Emmanuel, R., Hie, M., Gaëlle, C.R., Abad, S., Stanescu, D., Toutée, A., Gueudry, J., Bron, A., Kodjikian, L., Vincent, S., Fréderic, C., Titah, C., Emmanuel, H., Asma, M., Trad, S., Terrada, C., Nathalie, M., Domont, F., Anne-Claire, D., Maalouf, G., Vautier, M., Cacoub, P., Kristelle, D., Biard, L., and Bodaghi, B.

Published
2023
Full Text
View/download PDF

5. Laser Flare Photometry: A Useful Tool for Monitoring Patients with Juvenile Idiopathic Arthritis-associated Uveitis

Author

Or��s, Rapha��lle, Terrada, C��line, Errera, Marie-H��l��ne, Thorne, Jennifer E., Doukhan, Rapha��l, Cassoux, Nathalie, Penaud, Benjamin, LeHoang, Phuc, Quartier, Pierre Marie, and Bodaghi, Bahram

Subjects
genetic structures, eye diseases
Abstract

We evaluated laser flare photometry (LFP) values in patients with juvenile idiopathic arthritis (JIA)-associated uveitis. Retrospective study. A decrease of the LFP value between baseline visit and 1 month after anti-inflammatory treatment intensification allowed us to define two groups of patients: group 1 (decreased LFP value ���50%) and group 2 (p = .03) and final visit (p = .047). At the final visit, group 2 eyes had significantly more band keratopathy, trabeculectomy, cataract surgery, glaucoma and papille edema. Group 1 eyes kept a better visual acuity (p The decrease of LFP values ���50% of the initial value 1 month after treatment intensification is a good early prognostic factor.

Published
2020
Full Text
View/download PDF

8. Uveitis: From diagnosis to treatment [Uvéites : du diagnostic au traitement]

Author

Saadoun, D., Trad, S., Bielfeld, P., Sene, D., Abad, S., Kaplanski, G., Terrada, C., Kodjikian, L., Bodaghi, B., Seve, P., Université Pierre et Marie Curie - Paris 6 - UFR de Médecine Pierre et Marie Curie (UPMC), Université Pierre et Marie Curie - Paris 6 (UPMC), Service de médecine interne [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Service de médecine interne [Avicenne], Hôpital Avicenne, Vascular research center of Marseille (VRCM), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre recherche en CardioVasculaire et Nutrition (C2VN), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Matériaux, ingénierie et science [Villeurbanne] (MATEIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA), Equipe 14, Centre de Recherche en Cancérologie de Lyon (CRCL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

Subjects
treatment planning, uveitis, diagnostic procedure, Article, [SPI.MAT]Engineering Sciences [physics]/Materials
Abstract

cited By 0; International audience

Published
2018

9. Uvéites : du diagnostic au traitement

Author

Saadoun, D., primary, Trad, S., additional, Bielfeld, P., additional, Sene, D., additional, Abad, S., additional, Kaplanski, G., additional, Terrada, C., additional, Kodjikian, L., additional, Bodaghi, B., additional, and Seve, P., additional

Published
2018
Full Text
View/download PDF

12. Tuberculose oculaire

Author

Trad, S., primary, Saadoun, D., additional, Errera, M.H., additional, Abad, S., additional, Bielefeld, P., additional, Terrada, C., additional, Sène, D., additional, Bodaghi, B., additional, and Sève, P., additional

Published
2018
Full Text
View/download PDF

13. Management of uveomeningitis in internal medicine: Proposal for a diagnostic work-up

Author

Abad, S., Terrada, C., Trad, S., Sene, D., Bielefeld, P., Saadoun, D., Seve, P., Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Central Nervous System, Inflammation, therapy, Multiple Sclerosis, Sarcoidosis, Lymphoma, diagnosis, etiology, Eye Infections, Brain, [SDV.CAN]Life Sciences [q-bio]/Cancer, Syndrome, Nervous System, eye diseases, Autoimmune Diseases, Diagnosis, Differential, Uveitis, Practice Guidelines as Topic, Humans, Medicine, Meningitis, France, Uveomeningoencephalitic Syndrome, Algorithms
Abstract

International audience; Uveomeningitis relates to an inflammatory state extending from iris and ciliary bodies to the choroid behind the eye. Because of a close contact between eye and brain, and barrier disruption, the inflammation can spread into the central nervous system (CNS). We review the clinical manifestations of uveitis, which are known to provide helpful clues to the diagnosis and describe the infectious, inflammatory, and neoplastic conditions classically associated with the uveomeningitis. Inflammatory or auto-immune diseases are probably the most common clinically recognized causes of uveomeningitis associated with a significant pleiocytosis. These entities often cause inflammation of various tissues in the body, including ocular structures and the meninges (i.e., sarcoidosis, Behcet's disease, and Vogt-Koyanagi-Harada syndrome). The association of an infectious uveitis with an acute or a chronic meningo-encephalitis is unusual but occasionally the eye examination may suggest an infectious etiology or even a specific organism responsible for an uveomeningitis. One should consider the diagnosis of primary ocular-CNS lymphoma in patients of 40 years of age or older with bilateral uveitis, especially with prominent vitritis, showing poor response to corticosteroid therapy. Finally, an algorithm for the diagnostic approach of uveomeningitis is proposed

Published
2016

15. Oct-SD Versus Fluorescein Angiography For Evaluation Of Exudative Features In Wet Age-related Macular Degeneration

Author

Scemama Timsit, C., Giuseppe Querques, Terrada, C., Letien, V., Massamba, N., Mimoun, G., Souied, Eh, Scemama Timsit, C, Querques, Giuseppe, Terrada, C, Letien, V, Massamba, N, Mimoun, G, and Souied, Eh

Subjects
age-related macular degeneration • retina • imaging/image analysis: clinical [Keywords]
Abstract

Purpose:Imaging for evaluation of exudative signs in wet age-related macular degeneration (AMD) can be performed either on optical coherence tomography (OCT), fluorescein angiography (FA), or both. This study compares and analyzes OCT versus with FA exudative features in 117 eyes of 106 patients, during ranibizumab therapy in exudative AMD. Our purpose was to investigate whether examination with Spectral Domain OCT (SD-OCT) alone is sufficient to ascertain the need of re-treatment with ranibizumab in exudative AMD or if FA is needed. Methods:Retrospective, comparative study of 106 patients (117 eyes) with exudative AMD including 50 occult choroidal neovascularisation (type 1), 22 polypoidal choroidal vasculopathy (PCV), 23 chorioretinal anastomosis (CRA) and 22 classic choroidal neovascularisation (type 2). All cases were selected after the 6 first months of treatment by ranibizumab. SD-OCT and FA (Spectralis HRA-OCT Heidelberg Engineering, Heidelberg, Germany) were analyzed retrospectively and separately by 2 different experts (double reading). SD-OCT criteria for judgment of persistence of activity of the lesion were presence of any fluid, macular edema. FA criterion for judgment of persistence of activity of the lesion was leakage on late phases. The results of both imaging were compared in all sub-groups of wet AMD. Results:The mean age was 76,6 years; 29.8% were male, 70,2% female. In total among 117 eyes there was a 16,2 % conflict (19/117) between OCT and AF features. The divergence between FA and OCT was observed in 16% (8/50) of type 1, in 4.5 % (1/22) of CRA, in 4.3% (1/23) of PVC and in 50 % (11/22) of type 2 cases. Conclusions:Several studies demonstrated advantage of OCT-SD in detecting minor structural changes (cystoid macular edema, subretinal fluid, retinal pigment epithelium detachment increase, photoreceptor atrophy···). Our study shows the complementarities of these two imaging approaches. We suggest that FA should be performed on a regular basis in the follow-up of exudative AMD patients treated by anti-VEGF, particularly for type 2 CNV.

Published
2011

24. Azathioprine in severe uveitis of Behçet's disease

Author

Saadoun, D., primary, Wechsler, B., additional, Terrada, C., additional, Hajage, D., additional, Le Thi Huong, D., additional, Resche-Rigon, M., additional, Cassoux, N., additional, Le Hoang, P., additional, Amoura, Z., additional, Bodaghi, B., additional, and Cacoub, P., additional

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results